-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On MBX Biosciences with Buy Rating, Announces Price Target of $60

Benzinga·01/07/2026 20:23:14
語音播報
UBS analyst Michael Yee initiates coverage on MBX Biosciences (NASDAQ:MBX) with a Buy rating and announces Price Target of $60.